CuraCell TX AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Overview
- 5
- Employees
- 45K SEK
- Revenue
- 2020
- Founded
Key Decision Makers
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Thomas Jaecklin
Board Member
+6 more contacts in Funnelfeedr
Description
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559280854601
Decision Makers
10 contacts in FunnelfeedrHåkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Thomas Jaecklin
Board Member
Jonas Båtelson
CEO & Co-founder
Martin Forster
Board Member
Martina Ochel
COO
Per-Henrik Holmqvist
Head of CMC
Torbjörn Ström
Head of Clinical Operations
Other Contacts
Agnes Asp Sandin
Data Protection Officer
Similar Companies
20 similar companies in Funnelfeedr
Ultimovacs AB
0 employeesPioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
Anocca AB
100–199 employeesEngineering precision T-cell immunotherapies for hard-to-treat cancers.
SeqCure Immunology AB
1 employeesDeveloping personalized, non-genetically engineered cell therapy for advanced cancer.
ZELLUNA ASA
7 employeesPioneering TCR-NK cell therapies to eliminate solid cancers effectively.
ZELLUNA IMMUNOTHERAPY AS
9 employeesPioneering TCR-NK cell therapies to eliminate solid cancers safely.
Browse More
CuraCell TX AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo